A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity

JR Garlich, P De, N Dey, JD Su, X Peng, A Miller… - Cancer …, 2008 - aacrjournals.org
PTEN and the pan phosphoinositide 3-kinase (PI3K) inhibitor 2-(4-morpholinyl)-8-phenyl-4H-1benzopyran-4-one
(LY294002) exert significant control over tumor-induced angiogenesis …

RAC1 takes the lead in solid tumors

P De, JC Aske, N Dey - Cells, 2019 - mdpi.com
Three GTPases, RAC, RHO, and Cdc42, play essential roles in coordinating many cellular
functions during embryonic development, both in healthy cells and in disease conditions like …

Wnt signaling in triple negative breast cancer is associated with metastasis

N Dey, BG Barwick, CS Moreno, M Ordanic-Kodani… - BMC cancer, 2013 - Springer
Background Triple Negative subset of (TN) Breast Cancers (BC), a close associate of the
basal-like subtype (with limited discordance) is an aggressive form of the disease which …

The trastuzumab era: current and upcoming targeted HER2+ breast cancer therapies

J Kreutzfeldt, B Rozeboom, N Dey… - American journal of …, 2020 - pmc.ncbi.nlm.nih.gov
Human Epidermal Growth Factor Receptor 2-positive breast cancer (HER2+ BC) is defined
by increased amplification of the ERBB2/neu oncogene and/or overexpression of its …

PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

N Dey, P De, B Leyland-Jones - Pharmacology & therapeutics, 2017 - Elsevier
Breast cancer (BC) is the most common women cancer and second most common cause of
cancer death in women. A woman living in the United States has 12.3% lifetime risk of being …

The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration

N Dey, HE Crosswell, P De, R Parsons, Q Peng… - Cancer …, 2008 - aacrjournals.org
Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) is mutated or lost
in 60% to 70% of advanced gliomas and is associated with malignant phenotypic changes …

Differential activation of Wnt-β-catenin pathway in triple negative breast cancer increases MMP7 in a PTEN dependent manner

N Dey, B Young, M Abramovitz, M Bouzyk, B Barwick… - PloS one, 2013 - journals.plos.org
Mutations of genes in tumor cells of Triple Negative subset of Breast Cancer (TNBC) deregulate
pathways of signal transduction. The loss of tumor suppressor gene PTEN is the most …

ER+ metastatic breast cancer: Past, present, and a prescription for an apoptosis-targeted future

B Rozeboom, N Dey, P De - American journal of cancer …, 2019 - pmc.ncbi.nlm.nih.gov
The importance and role of the estrogen receptor (ER) pathway have been well-recognized
in both breast cancer development and progression. The treatment of choice in women with …

Doubling down on the PI3K-AKT-mTOR pathway enhances the antitumor efficacy of PARP inhibitor in triple negative breast cancer model beyond BRCA-ness

…, JH Carlson, LS Friedman, BR Leyland-Jones, N Dey - Neoplasia, 2014 - Elsevier
Phosphoinositide 3-kinase (PI3K) pathway, in addition to its pro-proliferative and antiapoptotic
effects on tumor cells, contributes to DNA damage repair (DDR). We hypothesized that …

Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors

N Dey, P De, LJ Brian - American journal of translational …, 2015 - pmc.ncbi.nlm.nih.gov
Vascular endothelial growth factor (VEGF) dependent tumor angiogenesis is an essential
step for the initiation and promotion of tumor progression. The hypothesis that VEGF-driven …